History: Endocrine syndrome (hypoglycemia, acute pancreatitis, upper abdominal pain) Clinical evaluation: Exclude diarrhea secondary to exocrine insufficiency, diabetes, and signs of portal hypertension Laboratory tests: Amylase, lipase, and/or peptide hormones (insulin, gastrin, glucagon, vasoactive intestinal polypeptide, pancreatic polypeptide, somatostatin, chromogranin A), tumor markers (CA 19-9, CEA, MCA, etc.). If an endocrine neoplasm is suspected, store a preoperative sample of serum and/or plasma for specific assays based on histologic and immuno-histochemical characterization of the resected lesion Imaging: Differential diagnosis and assessment of resectability based on ultrasonography, computed tomography, magnetic resonance imaging, or endoscopic ultrasonography
- 111In-pentetreotide scintigraphy (OctreoScan): endocrine neoplasms
- Positron emission tomography (PET): differentiates between benign and malignant lesions
Preoperative preparation: - Somatostatin analogues: no specific study on central pancreatectomy
- Perioperative antibiotics: as for any clean-contaminated operation
Was this article helpful?